A Belfast well being tech firm which helps deal with diabetes, weight problems and insomnia has appointed one of many world’s most revered medical gadget consultants.

Neurovalens has made Tina Lai Liedtky, President of the Clinical Diagnostics Division at Massachusetts-headquartered scientific companies big Thermo Fisher Scientific, as a non-executive director.

The firm, which creates non-invasive neurostimulation merchandise used to unravel a few of the world’s biggest well being challenges, stated Ms Liedtky will assist it safe medical gadget approvals and commercialize its expertise in each the metabolic and neurological space.

“I’m delighted to welcome Tina to our board of administrators at this essential time in Neurovalens’ development,” Dr Jason McKeown, Chief Executive of Neurovalens, stated. “Tina’s inspiring data of the medical gadget sector and her ardour for innovation can be key property.”

As President of Clinical Diagnostics at Thermo Fisher Scientific, Tina at present oversees a $1 billion division with over 2,300 staff. She has beforehand held industrial management roles for Abbott Diabetes Care, commercializing a breakthrough steady glucose monitoring gadget for diabetes administration, and Abbott Rapid Diagnostics, managing their Cardiometabolic enterprise with the world’s main point-of-care HbA1c platform.

She has additionally labored at Boston Scientific and Covidien (Medtronic) the place her focus was on alternatives to develop indications for the implanted neuromodulation expertise within the areas of headache and Parkinson’s illness, and within the space of neurovascular intervention.

“This is an thrilling time for Neurovalens as the corporate expands its platform expertise to handle Type 2 Diabetes and PTSD,” Tina Lai Liedtky stated. “The formidable goal of reaching a number of FDA approvals will permit them to deal with a few of the most difficult healthcare points the world over.

“I sit up for working carefully with Neurovalens’ management staff as they press ahead with their industrial technique.

Neurovalens, which is twin headquartered in each Belfast and San Diego, final yr raised £5.2m in funding from UK and Irish traders, which has been used to develop current scientific trials, fund new trials and develop the applying of its expertise to the remedy of a wider vary of situations.


Source link

#Belfast #well being #tech #agency #Neurovalens #appoints #world #medical #gadget #skilled #board

By Seth A. Dunbar

Seth Dunbar leads clinical research study operations and quality & compliance. He is experienced working with teams to help drug sponsors better leverage eSource data. With 10+ years of experience Seth brings expertise developing eClinical services that integrate data and technology to help companies optimise study execution.

Leave a Reply

Your email address will not be published. Required fields are marked *